113 related articles for article (PubMed ID: 36205715)
1. Difference in Lesion Reactivation between Pure Type 2 and Mixed Type 1 and 2 Macular Neovascularization and its Influence on Long-Term Treatment Outcomes.
Kim JH; Kim JW; Kim CG
Semin Ophthalmol; 2023 May; 38(4):358-364. PubMed ID: 36205715
[TBL] [Abstract][Full Text] [Related]
2. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.
Freund KB; Staurenghi G; Jung JJ; Zweifel SA; Cozzi M; Hill L; Blotner S; Tsuboi M; Gune S
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2437-2447. PubMed ID: 35239009
[TBL] [Abstract][Full Text] [Related]
3. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
[No Abstract] [Full Text] [Related]
4. Difference in characteristics and lesion reactivation between type 3 macular neovascularization with and without subretinal fluid at baseline.
Kim JH; Kim JW; Kim CG
Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):401-408. PubMed ID: 36112220
[TBL] [Abstract][Full Text] [Related]
5. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
[TBL] [Abstract][Full Text] [Related]
6. Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
Kim JH; Kim JW; Kim CG
J Ocul Pharmacol Ther; 2022 Apr; 38(3):261-268. PubMed ID: 35119292
[No Abstract] [Full Text] [Related]
7. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
8. OCT Predictors of 3-Year Visual Outcome for Type 3 Macular Neovascularization.
Sacconi R; Forte P; Tombolini B; Grosso D; Fantaguzzi F; Pina A; Querques L; Bandello F; Querques G
Ophthalmol Retina; 2022 Jul; 6(7):586-594. PubMed ID: 35227948
[TBL] [Abstract][Full Text] [Related]
9. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
[TBL] [Abstract][Full Text] [Related]
10. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
Steinle NC; Du W; Gibson A; Saroj N
Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of type 3 macular neovascularization using 3D volume-rendering OCTA.
Borrelli E; Mastropasqua L; Souied E; Sadda S; Vella G; Toto L; Miere A; Corradetti G; Sacconi R; Ferro G; Sarraf D; Querques L; Mastropasqua R; Bandello F; Querques G
Can J Ophthalmol; 2022 Aug; 57(4):228-235. PubMed ID: 34058145
[TBL] [Abstract][Full Text] [Related]
12. Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration.
Brynskov T; Munch IC; Larsen TM; Erngaard L; Sørensen TL
Acta Ophthalmol; 2020 Mar; 98(2):132-138. PubMed ID: 31282617
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial.
Jackson TL; Soare C; Petrarca C; Simpson A; Neffendorf JE; Petrarca R; Muldrew A; Peto T; Chakravarthy U; Membrey L; Haynes R; Costen M; Steel D; Desai R;
JAMA Ophthalmol; 2020 Aug; 138(8):835-842. PubMed ID: 32644148
[TBL] [Abstract][Full Text] [Related]
14. OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti-Vascular Endothelial Growth Factor Therapy.
Farinha C; Santos T; Santos AR; Lopes M; Alves D; Silva R; Cunha-Vaz J
Retina; 2020 May; 40(5):881-890. PubMed ID: 30689620
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
Monés J; Biarnés M;
Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111
[TBL] [Abstract][Full Text] [Related]
16. AGE-RELATED MACULAR DEGENERATION-ASSOCIATED PERIPAPILLARY CHOROIDAL NEOVASCULARIZATION IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lin T; Dans K; Meshi A; Muftuoglu IK; Amador-Patarroyo MJ; Chen KC; Cheng L; Freeman WR
Retina; 2019 Oct; 39(10):1936-1944. PubMed ID: 30028411
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of macular neovascularisation in geographic atrophy.
Sacconi R; Brambati M; Miere A; Costanzo E; Capuano V; Borrelli E; Battista M; Parravano M; Souied EH; Bandello F; Querques G
Br J Ophthalmol; 2022 Sep; 106(9):1282-1287. PubMed ID: 33836986
[TBL] [Abstract][Full Text] [Related]
18. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
19. Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment.
Cho HJ; Yoon W; Yoon J; Na SK; Lee J; Kim J; Kim CG; Kim JW
Am J Ophthalmol; 2022 Feb; 234():6-14. PubMed ID: 34339661
[TBL] [Abstract][Full Text] [Related]
20. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CAN CATEGORIZE DIFFERENT SUBGROUPS OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Arrigo A; Romano F; Aragona E; Di Nunzio C; Battista M; Bandello F; Battaglia Parodi M
Retina; 2020 Dec; 40(12):2263-2269. PubMed ID: 32032255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
